Inovio Pharmaceuticals Inc (NYSEMKT:INO) is offering more than 18.9 million common stock shares in the latest secondary offering. The offering has been priced at $2.90 per share, meaning that approximately $55 million could be raised in gross proceeds. The company has allowed the underwriters a 20-day option to acquire additional shares up to 2.8 million. This offering is expected to come to conclude on March 4. However, its closing is also subject to the customary conditions. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock opened at $3.50 in last session, and closed at $3.29, while the day range of INO stock is $3.20-$3.58.The stock showed a positive weekly performance of 2.17%.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its earnings data on Thursday. The Halozyme Therapeutics reported ($0.19) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.17) by $0.02, American Banking News.com reports. The company had revenue of $12.50 million for the quarter, compared to the consensus estimate of $21.80 million. During the same quarter in the prior year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was down 42.7% on a year-over-year basis. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock opened at $15.40, in last session and closed at $14.09, by loosed -12.05%.The 52 week range was $5.03-$18.18.Company’s market capitalization is $1.71 billion.
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) posted its quarterly earnings results on Thursday. The Idenix Pharmaceuticals reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.05, Analyst Ratings Network reports. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.15 million. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock loosed -3.67% and finished the last session at $6.82.The EPS of the stock remained -0.87.Company’s market capitalization is $1.03 billion.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) was last seen gaining almost 20 percent to $11.23 per share on Nasdaq, it was a trading session that was also characterized with high volume trading. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock opened the session at $11.62, and closed the session at $11.31. The 52 week range of the PRAN stock remained $2.11-$13.29 and the day range was $10.50-$12.22.